MX2021007626A - Formulacion de nicotina liquida de baja viscosidad. - Google Patents

Formulacion de nicotina liquida de baja viscosidad.

Info

Publication number
MX2021007626A
MX2021007626A MX2021007626A MX2021007626A MX2021007626A MX 2021007626 A MX2021007626 A MX 2021007626A MX 2021007626 A MX2021007626 A MX 2021007626A MX 2021007626 A MX2021007626 A MX 2021007626A MX 2021007626 A MX2021007626 A MX 2021007626A
Authority
MX
Mexico
Prior art keywords
nicotine formulation
liquid nicotine
aerosol
low viscosity
viscosity liquid
Prior art date
Application number
MX2021007626A
Other languages
English (en)
Inventor
Aline Vuarnoz-Bize
Robert Emmett
Jean-Pierre Schaller
Original Assignee
Philip Morris Products Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products Sa filed Critical Philip Morris Products Sa
Publication of MX2021007626A publication Critical patent/MX2021007626A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/05—Devices without heating means
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
    • A24F40/42—Cartridges or containers for inhalable precursors
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
    • A24F40/46—Shape or structure of electric heating means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Tobacco Products (AREA)

Abstract

Una formulación de nicotina líquida para su uso en un sistema generador de aerosol, la formulación de nicotina líquida comprende uno o más solventes miscibles en agua y tiene una viscosidad a 20 °C inferior o igual a aproximadamente 20 mPa·s, en donde la formulación de nicotina líquida tiene un contenido de solvente miscible en agua de entre aproximadamente 10 por ciento en peso y aproximadamente 50 por ciento en peso. Una formulación de nicotina líquida para su uso en un sistema generador de aerosol, la formulación de nicotina líquida comprende glicerina y tiene una viscosidad a 20 °C inferior o igual a aproximadamente 20 mPa·s, en donde la formulación de nicotina líquida tiene un contenido de glicerina superior o igual a aproximadamente 6 por ciento en peso. Un cartucho para su uso en un sistema generador de aerosol, el cartucho contiene la formulación de nicotina líquida. Un sistema generador de aerosol que comprende la formulación de nicotina líquida y un atomizador configurado para generar un aerosol a partir de la formulación de nicotina líquida.
MX2021007626A 2018-12-31 2019-12-31 Formulacion de nicotina liquida de baja viscosidad. MX2021007626A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP18215976 2018-12-31
EP18215983 2018-12-31
EP18215966 2018-12-31
EP18215969 2018-12-31
EP18215964 2018-12-31
PCT/EP2019/087202 WO2020141184A1 (en) 2018-12-31 2019-12-31 Low viscosity liquid nicotine formulation

Publications (1)

Publication Number Publication Date
MX2021007626A true MX2021007626A (es) 2021-08-11

Family

ID=69104449

Family Applications (5)

Application Number Title Priority Date Filing Date
MX2021007625A MX2021007625A (es) 2018-12-31 2019-12-31 Formulacion de nicotina liquida que comprende un solvente parcialmente soluble en agua.
MX2021007627A MX2021007627A (es) 2018-12-31 2019-12-31 Formulacion de nicotina liquida.
MX2021007624A MX2021007624A (es) 2018-12-31 2019-12-31 Formulacion de nicotina liquida.
MX2021007626A MX2021007626A (es) 2018-12-31 2019-12-31 Formulacion de nicotina liquida de baja viscosidad.
MX2021007623A MX2021007623A (es) 2018-12-31 2019-12-31 Formulacion liquida de nicotina que comprende solventes inmiscibles en agua.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
MX2021007625A MX2021007625A (es) 2018-12-31 2019-12-31 Formulacion de nicotina liquida que comprende un solvente parcialmente soluble en agua.
MX2021007627A MX2021007627A (es) 2018-12-31 2019-12-31 Formulacion de nicotina liquida.
MX2021007624A MX2021007624A (es) 2018-12-31 2019-12-31 Formulacion de nicotina liquida.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021007623A MX2021007623A (es) 2018-12-31 2019-12-31 Formulacion liquida de nicotina que comprende solventes inmiscibles en agua.

Country Status (9)

Country Link
US (5) US20220079211A1 (es)
EP (5) EP3905898B1 (es)
JP (5) JP2022516149A (es)
KR (5) KR20210110314A (es)
CN (5) CN113242696B (es)
BR (5) BR112021010222A2 (es)
MX (5) MX2021007625A (es)
UA (1) UA128585C2 (es)
WO (5) WO2020141178A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021010222A2 (pt) * 2018-12-31 2021-08-24 Philip Morris Products S.A. Formulação de nicotina líquida compreendendo solventes imiscíveis em água
KR102416605B1 (ko) 2021-08-17 2022-07-05 한국과학기술원 비트라인 멀티 레벨 전압 센싱 회로
IT202100027086A1 (it) * 2021-10-21 2023-04-21 Alberto Patarchi Erogatore portatile per il trattamento o la prevenzione di un’infezione o di una patologia causata da un virus
CN113912585B (zh) * 2021-11-09 2023-02-24 深圳萨特瓦生物科技有限公司 复合尼古丁盐及其制备方法与应用、电子烟油及电子烟
KR20240012197A (ko) * 2022-07-20 2024-01-29 주식회사 케이티앤지 표면파 아토마이저에 사용하기 위한 액상형 흡입제형, 이를 포함하는 카트리지 및 에어로졸 생성장치

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060018840A1 (en) 2004-06-28 2006-01-26 Nektar Therapeutics Aerosolizable formulation comprising nicotine
JP2006109784A (ja) 2004-10-15 2006-04-27 Mitsubishi Gas Chem Co Inc パクリタキセルの製造方法
WO2007032962A2 (en) 2005-09-09 2007-03-22 University Of Kentucky Compositions and methods for intranasal delivery of tricyclic cannabinoids
WO2007078273A1 (en) * 2005-12-22 2007-07-12 Augite Incorporation No-tar electronic smoking utensils
US20090181080A1 (en) 2007-08-06 2009-07-16 Insys Therapeutics Inc. Oral cannabinnoid liquid formulations and methods of treatment
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
US20120325228A1 (en) * 2011-06-23 2012-12-27 Williams Jonnie R Alkaloid composition for e-cigarette
DE102011114094A1 (de) * 2011-09-21 2013-03-21 F. Holzer Gmbh Stimulierendes und belebendes Nasenspray und Nasentropfen
AU2013242200B2 (en) * 2012-03-27 2017-03-02 Nicoccino Ab Nicotine formulation
RU2659887C2 (ru) 2013-05-06 2018-07-04 Джуул Лэбз, Инк. Составы на основе солей никотина для аэрозольных устройств и способы их применения
US20150013695A1 (en) * 2013-07-10 2015-01-15 Ahkeo Ventures LLC Inhalable compositions comprising caffeine, methods of use and an apparatus for using the same
US10660365B2 (en) 2013-07-19 2020-05-26 Altria Client Services Llc Liquid aerosol formulation of an electronic smoking article
AU2014323044B2 (en) * 2013-09-19 2019-02-28 Philip Morris Products S.A. Aerosol-generating system for generating nicotine salt particles
WO2015042589A1 (en) 2013-09-23 2015-03-26 Verso PV, LLC Personal vaporizer liquid for emulsifying oil-soluble compounds and resins
US9333229B2 (en) 2013-10-16 2016-05-10 William Bjorncrantz Winterized crude cannabis extracts and methods of preparation and use
US10292424B2 (en) 2013-10-31 2019-05-21 Rai Strategic Holdings, Inc. Aerosol delivery device including a pressure-based aerosol delivery mechanism
CN103622161A (zh) 2013-11-28 2014-03-12 刘秋明 一种电子烟烟液溶剂及电子烟烟液
CN103598672A (zh) 2013-11-28 2014-02-26 刘秋明 一种电子烟烟液溶剂及电子烟烟液
EP3076805A4 (en) 2013-12-05 2017-10-11 PAX Labs, Inc. Nicotine liquid formulations for aerosol devices and methods thereof
WO2015117243A1 (en) 2014-02-07 2015-08-13 Bellerose Samuel Liquid formulation for e-cigarettes
GB201407426D0 (en) 2014-04-28 2014-06-11 Batmark Ltd Aerosol forming component
US20150313275A1 (en) 2014-04-30 2015-11-05 Altria Client Services, Inc. Liquid aerosol formulation of an electronic smoking article
PT3639813T (pt) * 2014-05-21 2022-03-01 Mcneil Ab Uma formulação líquida que inclui nicotina para administração aerossol
RU2685331C2 (ru) * 2014-07-11 2019-04-17 Филип Моррис Продактс С.А. Система, генерирующая аэрозоль, с улучшенным управлением потоком воздуха
MX2017000489A (es) * 2014-07-11 2017-04-27 Philip Morris Products Sa Cartucho formador de aerosol que comprende una fuente de nicotina liquida.
CN104256885B (zh) * 2014-08-05 2015-12-30 云南中烟工业有限责任公司 一种电子烟烟液溶剂
GB2535427A (en) * 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
GB2532062A (en) 2014-11-07 2016-05-11 Nicoventures Holdings Ltd Container
CN104473323A (zh) 2014-12-03 2015-04-01 河南中烟工业有限责任公司 一种电子烟雾化剂
CN104585880B (zh) * 2015-01-20 2018-06-08 湖北中烟工业有限责任公司 一种用于烟用滴丸的薄荷香精溶剂
CN104939305B (zh) * 2015-05-20 2016-04-20 湖南中烟工业有限责任公司 一种烟草提取物及电子烟液
US20160345621A1 (en) * 2015-06-01 2016-12-01 San Li Pre-vapor formulation of an electronic vaping device and/or methods of manufacturing the same
GB2542389A (en) * 2015-09-17 2017-03-22 Kind Consumer Ltd Simulated cigarette
US10327472B2 (en) * 2015-09-25 2019-06-25 Altria Client Services Llc Pre-vaporization formulation for controlling acidity in an e-vaping device
CN106562469A (zh) * 2015-10-07 2017-04-19 惠州市吉瑞科技有限公司 电子烟烟液
EP3782680B1 (en) * 2015-11-02 2023-11-29 Philip Morris Products S.A. An aerosol-generating system comprising a vibratable element
GB2544468A (en) 2015-11-12 2017-05-24 Jaytee Biosciences Ltd Liquid formulation
US20170216172A1 (en) * 2016-01-29 2017-08-03 The Procter & Gamble Company Composition for Enhancing Hair Fiber Properties
US20170325494A1 (en) * 2016-05-16 2017-11-16 Lunatech, Llc Liquid composition containing nicotine from non-tobacco source for use with electronic vaporizing devices
CA3016255A1 (en) * 2016-05-27 2017-11-30 Philip Morris Products S.A. Aerosol-generating article having a liquid indicator
US20170348494A1 (en) * 2016-06-06 2017-12-07 Nicholas A. Havercroft Pulmonary device, method and system for delivering a pharmaceutical product to an individual
US20170367386A1 (en) 2016-06-24 2017-12-28 Allied Concessions Group, Inc. Terpene flavoring compositions
CN106036990B (zh) * 2016-08-03 2018-10-12 华健 一种复合醇电子烟雾化液
US20180084823A1 (en) 2016-09-27 2018-03-29 BOND STREET MANUFACTURING LLC (a Florida LLC) Vaporizable Tobacco Wax Compositions and Container thereof
US20180103680A1 (en) 2016-10-18 2018-04-19 Altria Client Services Llc Methods and systems for improving stability of the pre-vapor formulation of an e-vaping device
US11785677B2 (en) * 2017-06-08 2023-10-10 Altria Client Services Llc Cartridge having a susceptor material
KR20210011911A (ko) 2018-05-16 2021-02-02 필립모리스 프로덕츠 에스.에이. 분무기 및 그를 위한 메쉬
CN112040798B (zh) 2018-05-16 2024-04-05 菲利普莫里斯生产公司 具有振动室的雾化器组件
BR112021010222A2 (pt) * 2018-12-31 2021-08-24 Philip Morris Products S.A. Formulação de nicotina líquida compreendendo solventes imiscíveis em água
WO2020248071A1 (en) * 2019-06-12 2020-12-17 Lunaverse Inc. Method and system for trichome isolation

Also Published As

Publication number Publication date
CN113163845A (zh) 2021-07-23
EP3905897A1 (en) 2021-11-10
EP3905898A1 (en) 2021-11-10
EP3905900C0 (en) 2024-05-15
MX2021007623A (es) 2021-08-11
EP3905898C0 (en) 2024-05-08
WO2020141176A1 (en) 2020-07-09
EP3905899A1 (en) 2021-11-10
KR20210108384A (ko) 2021-09-02
CN113242696A (zh) 2021-08-10
US20220053817A1 (en) 2022-02-24
EP3905901A1 (en) 2021-11-10
CN113163845B (zh) 2023-04-28
WO2020141180A1 (en) 2020-07-09
JP2022516896A (ja) 2022-03-03
MX2021007625A (es) 2021-08-11
WO2020141178A1 (en) 2020-07-09
BR112021009726A2 (pt) 2021-08-17
MX2021007627A (es) 2021-08-11
CN113163848A (zh) 2021-07-23
WO2020141184A1 (en) 2020-07-09
CN113242696B (zh) 2023-04-28
CN113163847B (zh) 2023-01-10
KR20210108394A (ko) 2021-09-02
CN113163848B (zh) 2023-06-20
EP3905900B1 (en) 2024-05-15
KR20210109548A (ko) 2021-09-06
KR20210108390A (ko) 2021-09-02
CN113163846B (zh) 2023-04-28
MX2021007624A (es) 2021-08-11
JP2022516149A (ja) 2022-02-24
EP3905900A1 (en) 2021-11-10
WO2020141177A1 (en) 2020-07-09
JP2022515983A (ja) 2022-02-24
CN113163846A (zh) 2021-07-23
US11992038B2 (en) 2024-05-28
US20220079211A1 (en) 2022-03-17
JP2022516895A (ja) 2022-03-03
KR20210110314A (ko) 2021-09-07
US20220079210A1 (en) 2022-03-17
BR112021010614A2 (pt) 2021-08-24
EP3905898B1 (en) 2024-05-08
BR112021010593A2 (pt) 2021-08-24
US20220071269A1 (en) 2022-03-10
BR112021010284A2 (pt) 2021-08-17
BR112021010222A2 (pt) 2021-08-24
US20220071270A1 (en) 2022-03-10
CN113163847A (zh) 2021-07-23
UA128585C2 (uk) 2024-08-21
JP2022515021A (ja) 2022-02-17

Similar Documents

Publication Publication Date Title
MX2021007626A (es) Formulacion de nicotina liquida de baja viscosidad.
MX2019000150A (es) Composiciones de microcapsulas estables.
EP4342312A3 (en) Tobacco composition
MX2016015179A (es) Una formulación líquida que comprende nicotina para administracion en aerosol.
WO2019079743A8 (en) Compositions for hemolysis and coagulation regulation and stabilization of extracellular vesicles
MX2019007869A (es) Composiciones adyuvantes de reduccion de deriva y metodos de uso de las mismas.
PH12019500034A1 (en) Systems, devices, and methods for conversion of consumption of aerosol-generating articles
MX2018000894A (es) Composicion de fragancia a base de agua, dispositivo de suministro de fragancia, y metodo para proporcionar un perfume de larga duracion.
EP3898922A4 (en) SOLVENT COMPOSITIONS CONTAINING 1,2,2-TRIFLUORO-1-TRIFLUOROMETHYLCYCLOBUTANE (TFMCB)
MX2018010788A (es) Composicion oftalmologica.
MX356265B (es) Composicion en aerosol que comprende un almidon de tapioca particulado.
MX2016004018A (es) Recubrimiento intumescente a base de poliisocianato.
MX2021005123A (es) Formulacion aerosolizable.
PH12018502615A1 (en) Depot formulations
MX2021005117A (es) Formulacion aerosolizable.
WO2015171460A3 (en) Formulations of cyclophosphamide liquid concentrate
PH12018500095B1 (en) Thickening agent for aqueous systems, formulations containing same and uses thereof
JP2016510082A5 (es)
MX2023007117A (es) Formulacion liquida para preparar un vehiculo de suministro que comprende un polimero termosensible y un polimero sensible a iones.
WO2018141941A3 (en) Methods and systems for improving stability of pre-vapor formulations of e-vaping devices
MY184150A (en) Preparation of polyamidoimides
EP3873471A4 (en) N-HETEROARYL INDAZOLE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND THEIR USES
ZA202100040B (en) Aerosolisable formulation
BR112018008919A8 (pt) dispensador de gel de transporte sem aspiração
EA202192475A1 (ru) Способ получения стабильных пептидных составов